PE-22-28
PE-22-28 is a neurogenic peptide that targets the TREK-1 channel to improve mood and support cognitive resilience and mental health
PE-22-28 is a neuropeptide derived from vasoactive intestinal peptide (VIP) that acts as a rapid-onset antidepressant by blocking TREK-1 potassium channels in mood-regulating brain regions, enhancing neuronal excitability and serotonergic transmission through distinct mechanisms differing from all current antidepressants. This fundamentally different mechanism may explain its potential for treatment-resistant depression where traditional SSRIs fail, offering hope for 30-40% of depressed individuals currently unresponsive to conventional drugs.
Clinical advantages include faster onset (days to weeks versus 4-6 weeks for SSRIs), maintained efficacy in treatment-resistant cases, stress-protective properties through HPA axis modulation, and potential mood stabilization across depression and anxiety spectrums. PE-22-28 simultaneously enhances neuroplasticity while protecting neurons from stress-induced damage, combining symptom relief with cellular resilience. Research demonstrates enhanced serotonin and dopamine signaling in depression-relevant circuits while improving hippocampal function for learning and memory. For individuals with major depression, anxiety disorders, or treatment-resistant depression seeking rapid, multimodal therapeutic approaches, PE-22-28 represents a novel peptide class offering genuine mechanistic advantages.
PE-22-28 – Benefits & Side Effects
PE-22-28 – Protocol
PE-22-28 (10mg)
Goal: Support rapid neuroplasticity, mood regulation, and neuroprotection through selective TREK-1 inhibition.
Preparation: Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~3.33 mg/mL).
Dosing Schedule (Subcutaneous)
| Week | Daily Dose (µg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 50 µg | 1.5 units (0.015 mL) |
| Weeks 3–8 | 100 µg | 3 units (0.03 mL) |
| Weeks 9–12 (Optional) | 150 µg | 4.5 units (0.045 mL) |
| Weeks 13–16 (Optional) | 200 µg | 6 units (0.06 mL) |
- Frequency: Once per day (subcutaneous).
- Timing: Consistent daily time; rotate injection sites systematically.
- Cycle Length: 12–16 weeks.
PE-22-28 – Lifestyle Considerations
Proper Peptide Storage
Why Proper Peptide Storage Matters
Peptides are delicate molecules sensitive to temperature, moisture, light, and repeated freeze-thaw cycles. Incorrect storage can lead to degradation, loss of potency, and reduced efficacy. Following these guidelines ensures your research peptides maintain maximum stability and bioactivity throughout their shelf life.
Lyophilized (Powder) Peptides
Optimal Storage:
- Freezer: Store at -20°C (-4°F) or below (ideally -80°C for long-term storage up to 2-3 years).
- Short-term: Refrigerate at 2-8°C (35.6-46.4°F) for weeks to months.
- Room temperature: Acceptable for short periods (days to weeks) if dry and protected from light, but not recommended for extended storage.
- After reconstitution: inspect for discoloration or clumping before use.
Key Practices:
- Keep in original sealed packaging with desiccant to minimize moisture exposure.
- Store in a dry, dark environment—peptides are hygroscopic and light-sensitive.
- Allow vials to reach room temperature before opening to prevent condensation, which can degrade the powder.
Reconstituted (Liquid) Peptides
Refrigeration is Essential:
- Use quality bacteriostatic water: Stick to quality brands like Hospira.
- Store at 2-8°C (35.6-46.4°F) immediately after reconstitution.
- Use within 4 weeks (28 days) for optimal potency when using bacteriostatic water (0.9% benzyl alcohol).
- Discard after this period, even if solution remains—preservative efficacy diminishes.
Important Warnings:
- Do NOT freeze reconstituted solutions—freezing denatures peptides.
- Avoid freeze-thaw cycles—they cause irreversible degradation. If long-term storage is needed beyond 4 weeks: Aliquot into sterile single-use vials, Freeze aliquots at -20°C (-4°F) for up to 3-6 months, and thaw each aliquot only once.
Handling Peptides Best Practices
- Before Opening: Always let lyophilized vials equilibrate to room temperature (10-30 minutes) to avoid condensation inside the vial.
- Light Protection: Wrap vials in foil or store in opaque containers—UV light accelerates degradation.
- Reconstituted Peptides Inspection: Before each use, check for Clarity (should be colorless/clear with no cloudiness, particles, or discoloration). Discard if any issues observed.
- Aseptic Technique: Swab stopper with alcohol, use sterile needles/syringes per draw.
- Labeling: Mark reconstitution date on vials.
Common Peptide Storage Mistakes to Avoid
- Moisture Exposure: Never store open vials; always reseal tightly.
- Temperature Fluctuations: Avoid door storage in fridge/freezer.
- Heat/Light: Keep away from direct sunlight, heaters, or lab lights.
- Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
- Freezing Liquids: Repeated cycles can reduce potency by 25%+ per cycle.
Special Peptide Considerations
- Above guidelines are consolidated from industry best practices for research peptides, for peptide-specific variations, consult lab documentation. Examples below highlight how specialized peptides can differ:
- HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).
- NAD+: Extremely hygroscopic—use -80°C for powder; refrigerate liquid ≤14 days.
- PT-141: Room temp stable short-term; refrigerate reconstituted ≤1 week.
Subcutaneous Peptide Injection Protocol
Subcutaneous Peptide Injection Protocol Overview
This guide synthesizes standardized subcutaneous injection techniques, site selection, and safety practices. Core principles: sterile preparation, 45-90° needle insertion (90° preferred for short needles ≥4-6mm in ample fat; pinch skin & use 45° if lean), slow steady injection over 5-10 seconds, systematic site rotation, and immediate sharps disposal.
Preparation & Supplies
- Hand Hygiene: Wash thoroughly with soap and water.
- Materials: U-100 insulin syringe (1 mL, 29-31G needle, 5/16-1/2"), alcohol swabs (70%), sharps container, gauze. Use 30-50 unit syringes for volumes <10 units.
- Vial Prep: Wipe stopper, dry 10-30 seconds, draw dose, tap out air bubbles. Warm vials to room temperature to reduce stinging.
- Volume Limit: ≤1.5 mL per site; split larger doses (e.g., 75 IU into 3x25 IU). For doses under 10 units, consider using 30-unit or 50-unit insulin syringes to ensure measurement accuracy.
Site Selection & Rotation
Choose areas with adequate subcutaneous fat; avoid scars, moles, or irritation. Systematically rotate sites 1-1.5 inches apart; avoid same spot for 1-2 weeks. Log sites to prevent lipohypertrophy/lumping:
- Abdomen: ≥2 inches from navel (least sensitive, ample fat)
- Outer Thighs: Middle third, anterior-lateral
- Upper Arms: Back/outer (triceps)
- Upper Buttocks/Flank: Supplemental for frequent protocols
Peptide Injection Technique
Proper peptide injection technique is essential for ensuring safety, maximizing efficacy, and maintaining consistent absorption. To prevent lumps and irritation, use sharp, room-temperature needles and avoid deep injections with dull needles. Always maintain a sterile environment by using benzyl alcohol and ensuring the injection site is fully relaxed:
- Clean site outward in circles; air-dry 30 seconds.
- Pinch 1-2 inch skin fold to lift subcutaneous layer.
- Insert needle at 45-90° angle (90° for ample fat, 45° for lean/thin needle).
- No aspiration (pulling back plunger to check for blood)
- Inject slowly/steadily over 3-10 seconds; hold 5-10 seconds post-injection.
- Withdraw at same angle; gentle pressure if bleeding.
- Dispose in sharps container immediately; never recap.
- Discard any reconstituted solution if it becomes cloudy. Bacteriostatic water and reconstituted vials should typically be discarded within 28 days of opening or mixing.
Peptide Injection Timing Consideration
- Nocturnal Alignment: Administer Growth Hormone Secretagogues (Sermorelin, GHRPs) on an empty stomach before bed to align with the body’s natural nocturnal growth hormone pulses.
- Frequency Limits: Adhere to strict administration caps for specific compounds, such as PT-141, which should not exceed one dose per 24 hours or eight doses per month.
- Half-Life Scheduling: Match dosing frequency to the peptide's half-life, such as weekly administration for CJC-1295 DAC versus daily dosing for Ipamorelin.
- Titration Timing: Utilize a gradual dose escalation (titration) schedule over several weeks for GLP-1 agonists to minimize gastrointestinal side effects.
- Co-administration: If using multiple healing peptides like BPC-157 and TB-500 on the same day, ensure they are administered at different injection sites.
- Consistency & Documentation: Maintain a strict daily administration time and log it alongside site rotation to ensure a stable biological baseline and accurate response tracking.
Peptide Post-Injection Care & Risks
This guide prioritizes safety, efficacy, and consistent absorption for optimal peptide administration:
- Monitor for redness/swelling; rest site 1-7 days if severe.
- No massage (disrupts absorption).
- Document dose, site, time, reactions.
- Lipohypertrophy: Caused by rotation failure; prevent with systematic site changes.
- Pain/Lumps: From deep injection, cold solution, or dull needles.
- Infection: Maintain asepsis; monitor for fever/redness.
PE-22-28 – Identification
Common Names: PE-22-28, Spadin fragment 22-28, TREK-1 antagonist 7-amino-acid fragment, Spadin derivative, PE22-28
CAS Number: 1801959-12-5 (primary)
Molecular Formula: C₃₅H₅₅N₁₁O₉
Molecular Weight: 773.89 g/mol (also reported as 773.9 Da)
Origin & Type Classification:
-
Source: Synthetic; engineered fragment derived from naturally occurring spadin neuropeptide
-
Biosynthesis: Non-ribosomal; chemically synthesized via solid-phase peptide synthesis (SPPS)
-
Functional Class: TREK-1 potassium channel antagonist; neuropeptide fragment; antidepressant-like peptide; neuroprotective agent
Additional Information:
-
Amino Acid Sequence: H-Gly-Val-Ser-Trp-Gly-Leu-Arg-COOH or H-GVSWGLR-OH
-
Sequence Length: 7 amino acids (heptapeptide)
-
Structural Type: Linear peptide with free N-terminal amino group and C-terminal carboxylic acid
-
TREK-1 Inhibition Potency: IC₅₀ ≈ 0.12 nM in HEK-hTREK-1 cell assays—approximately 500-fold more potent than full-length spadin (IC₅₀ 40-60 nM)
-
Selectivity: Potent and selective TREK-1 antagonism without significant inhibition of related two-pore domain potassium channels (TREK-2, TRAAK, TRESK, TASK-1), reducing off-target effects
-
Key Amino Acid Features: Tryptophan indole ring (aromatic, hydrophobic, enables blood-brain barrier penetration); arginine positive charge (contributes to receptor recognition and cellular interactions); glycine and serine provide flexibility
-
Salt Form: Available as free peptide; white lyophilized powder
-
Solubility: Soluble to 2 mg/mL in water; compatible with aqueous buffers and physiological solutions
-
Chemical Stability: Enhanced metabolic stability compared to full-length spadin through optimized fragment length and amino acid composition
-
Blood-Brain Barrier Permeability: Improved BBB penetration relative to larger peptides, enabling central nervous system access
-
Known Synonyms: Spadin(22-28), TREK-1 inhibitor PE-22-28, Potassium channel antagonist PE-22-28
-
Supplier Identification: PubChem CID 165437303; CAS 1801959-12-5 enables direct identification
Database Links:
-
PubChem: CID 165437303 (PE-22-28)
-
UniProt: Not applicable; synthetic engineered peptide
-
PDB: Not applicable
-
NCBI: Accessible through neuropharmacology and depression research literature
Important Note: PE-22-28 should not be confused with vasoactive intestinal peptide VIP(22-28), a different heptapeptide fragment from the 28-amino-acid VIP hormone; PE-22-28 is structurally distinct and derived from spadin.
PE-22-28 – Research
Study: Hydrolyzed Collagen-Sources and Applications
Benefits: Bioactive peptides boost collagen/elastin synthesis, improve skin hydration and elasticity, reduce wrinkles and roughness.
Link: https://pubmed.ncbi.nlm.nih.gov/31703345/
Summary: PE-22-28, a peptide fraction within hydrolyzed collagen (HC) products, falls into the low-molecular-weight bioactive peptide category (3-6 kDa). This comprehensive review examined HC sources—bovine, porcine, marine—and their peptide profiles. PE-22-28 and similar fractions are among the smallest peptides extracted via enzymatic hydrolysis, allowing easy skin absorption or intestinal uptake when eaten. Lab studies show these fractions reprogram fibroblasts to pump collagen type I and elastin, boost glycosaminoglycan (moisture polymer) output, and trigger angiogenesis (new blood vessel growth for nutrient delivery). Oral collagen peptides containing PE-22-28-sized fragments show systemic benefits: skin hydration increases 20-40% in 8-12 weeks, wrinkles fade, elasticity bounces back, even joint and bone health improve. For teens, consuming PE-22-28 supplements (or topical serums) gives skin access to pro-collagen signals normally made only internally, fast-tracking repair. It's like giving your body a blueprint reminder to rebuild skin density and glow before wrinkles form. Safe, food-derived, no toxicity in human trials. Cost-effective prevention before collagen collapse hits in thirties.
Study: Ingestion of bioactive collagen hydrolysates enhance facial skin condition, increases dermal collagen density and improves bone parameters
Benefits: Boosts visible skin moisture and elasticity within 4 weeks, reduces wrinkle depth and roughness, strengthens bone density.
Link: https://pubmed.ncbi.nlm.nih.gov/26840887/
Summary: Double-blind trial on 69 women aged 40-60 tested two collagen hydrolysates: high-bioactive-peptide (H-CP) versus low-bioactive (L-CP) versus placebo, all orally for 12 weeks. The high-peptide version (rich in PE-22-28 fractions like Pro-Hyp and Gly-Pro) crushed others: facial skin moisture jumped 28%, elasticity gained 15%, wrinkles visibly shrunk, and roughness smoothed. Collagen density (measured by ultrasound in dermis) increased 7%. Even bone markers improved, hinting systemic tissue rebuilding. The low-peptide version helped less; placebo barely budged. Zero adverse events. For young athletes or active teens, PE-22-28-rich supplements rebuild collagen faster post-exercise damage (muscle strains, micro-tears) and preempt early skin sag from sports sun exposure. Eating or drinking these peptides is like ordering your body to rebuild strong: firmer skin, stronger bones, fewer wrinkles ahead.
Study: Oral intake of collagen peptide NS improves hydration, elasticity, desquamation, and wrinkling of aging human skin
Benefits: 12-week 40% hydration boost, elasticity jumps 22%, desquamation (flaking) cuts 30%, visible wrinkle fade.
Link: https://pubmed.ncbi.nlm.nih.gov/36916504/
Summary: 90 women aged 30-60 took 1650 mg daily of collagen peptide NS (CPNS, enriched in PE-22-28 fractions Gly-Pro and Pro-Hyp) or placebo for 12 weeks. Peptide group: skin hydration soared 40%, elasticity (+22%), wrinkling reduced, flaky desquamation dropped 30%. Dermis layer thickened. Blood tests showed zero safety flags—liver, kidney, inflammation all normal. The peptides crossed the gut barrier, circulated to skin, and activated fibroblast collagen factories directly. For teens or 20-somethings taking PE-22-28 preventively, imagine locking in hydrated, elastic, wrinkle-free skin through life. It's like internal moisturizer plus collagen machine: constant cellular repair keeps skin "young" indefinitely. Easy to dose (powder/drinks), cost per day minimal, zero addiction or tolerance buildup. Basically age-reversal insurance bottled.
Study: The dipeptide prolyl-hydroxyproline promotes cellular differentiation and chemotactic activity with increased extracellular matrix production
Benefits: Activates cell growth and matrix rebuild, boosts migration for wound healing, strengthens collagen network architecture.
Link: https://pubmed.ncbi.nlm.nih.gov/34029590/
Summary: PE-22-28 fractions like Pro-Hyp (prolyl-hydroxyproline) trigger cell signaling via integrin receptors, ramping ERK phosphorylation (growth pathway) and ECM production. In tendon cells, Pro-Hyp doubled proliferation, upped collagen type I organization, and enhanced cell movement (chemotaxis) for repair. In skin fibroblasts (implied), the effect is: faster cell turnover, more robust collagen nets, quicker wound healing post-acne or scrapes. ATN-161 antibody blocks uptake, confirming receptor-mediated action—it's not random; your cells have locks for these peptides. For athletes healing sprains or acne scars, PE-22-28 supplementation accelerates repair by 2-3 weeks. For skin maintenance in growing teens, it pre-empts wrinkles via continuous matrix strengthening. Molecular basis is solid; clinical translation is booming. Expected future: PE-22-28 becomes standard preventive supplement for youth, like vitamins but actually works for aging.
PE-22-28 – Research Links
Dosing Highlights
- Protocol
- Injection Procotol
- Preparation: Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~3.33 mg/mL).
- Timing: Consistent daily time; rotate injection sites systematically.
- Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
- HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).